224 related articles for article (PubMed ID: 31672859)
1. A Multiplex, Droplet Digital PCR Assay for the Detection of T-Cell Receptor Excision Circles and Kappa-Deleting Recombination Excision Circles.
Profaizer T; Slev P
Clin Chem; 2020 Jan; 66(1):229-238. PubMed ID: 31672859
[TBL] [Abstract][Full Text] [Related]
2. Establishing Simultaneous T Cell Receptor Excision Circles (TREC) and K-Deleting Recombination Excision Circles (KREC) Quantification Assays and Laboratory Reference Intervals in Healthy Individuals of Different Age Groups in Hong Kong.
Kwok JSY; Cheung SKF; Ho JCY; Tang IWH; Chu PWK; Leung EYS; Lee PPW; Cheuk DKL; Lee V; Ip P; Lau YL
Front Immunol; 2020; 11():1411. PubMed ID: 32765500
[TBL] [Abstract][Full Text] [Related]
3. Determining T and B Cell development by TREC/KREC analysis in primary immunodeficiency patients and healthy controls.
Şentürk G; Ng YY; Eltan SB; Başer D; Ogulur I; Altındirek D; Fırtına S; Yılmaz H; Kocamış B; Kıykım A; Camcıoğlu Y; Ar MC; Sudutan T; Beken S; Temel ŞG; Alanay Y; Karakoc-Aydiner E; Barış S; Özen A; Özbek U; Sayitoğlu M; Hatırnaz Ng Ö
Scand J Immunol; 2022 Mar; 95(3):e13130. PubMed ID: 34951041
[TBL] [Abstract][Full Text] [Related]
4. Determining Laboratory Reference Values of TREC and KREC in Different Age Groups of Iranian Healthy Individuals.
Shakerian L; Pourpak Z; Shamlou S; Domsgen E; Kazemnejad A; Dalili H; Nourizadeh M
Iran J Allergy Asthma Immunol; 2019 Apr; 18(2):143-152. PubMed ID: 31066250
[TBL] [Abstract][Full Text] [Related]
5. Newborn Screening for Severe Primary Immunodeficiency Diseases in Sweden-a 2-Year Pilot TREC and KREC Screening Study.
Barbaro M; Ohlsson A; Borte S; Jonsson S; Zetterström RH; King J; Winiarski J; von Döbeln U; Hammarström L
J Clin Immunol; 2017 Jan; 37(1):51-60. PubMed ID: 27873105
[TBL] [Abstract][Full Text] [Related]
6. A Droplet Digital PCR Method for Severe Combined Immunodeficiency Newborn Screening.
Vidal-Folch N; Milosevic D; Majumdar R; Gavrilov D; Matern D; Raymond K; Rinaldo P; Tortorelli S; Abraham RS; Oglesbee D
J Mol Diagn; 2017 Sep; 19(5):755-765. PubMed ID: 28826609
[TBL] [Abstract][Full Text] [Related]
7. The TREC/KREC assay for the diagnosis and monitoring of patients with DiGeorge syndrome.
Froňková E; Klocperk A; Svatoň M; Nováková M; Kotrová M; Kayserová J; Kalina T; Keslová P; Votava F; Vinohradská H; Freiberger T; Mejstříková E; Trka J; Sedivá A
PLoS One; 2014; 9(12):e114514. PubMed ID: 25485546
[TBL] [Abstract][Full Text] [Related]
8. Newborn screening for severe T and B cell immunodeficiency in Israel: a pilot study.
Somech R; Lev A; Simon AJ; Korn D; Garty BZ; Amariglio N; Rechavi G; Almashanu S; Zlotogora J; Etzioni A
Isr Med Assoc J; 2013 Aug; 15(8):404-9. PubMed ID: 24079059
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous quantification of T-cell receptor excision circles (TRECs) and K-deleting recombination excision circles (KRECs) by real-time PCR.
Sottini A; Serana F; Bertoli D; Chiarini M; Valotti M; Vaglio Tessitore M; Imberti L
J Vis Exp; 2014 Dec; (94):. PubMed ID: 25549107
[TBL] [Abstract][Full Text] [Related]
10. TREC/KREC Newborn Screening followed by Next-Generation Sequencing for Severe Combined Immunodeficiency in Japan.
Wakamatsu M; Kojima D; Muramatsu H; Okuno Y; Kataoka S; Nakamura F; Sakai Y; Tsuge I; Ito T; Ueda K; Saito A; Morihana E; Ito Y; Ohashi N; Tanaka M; Tanaka T; Kojima S; Nakajima Y; Ito T; Takahashi Y
J Clin Immunol; 2022 Nov; 42(8):1696-1707. PubMed ID: 35902420
[TBL] [Abstract][Full Text] [Related]
11. Limitation of Simultaneous Analysis of T-Cell Receptor and κ-Deleting Recombination Excision Circles Based on Multiplex Real-Time Polymerase Chain Reaction in Common Variable Immunodeficiency Patients.
Atschekzei F; Ahmad F; Witte T; Jacobs R; Schmidt RE
Int Arch Allergy Immunol; 2016; 171(2):136-140. PubMed ID: 27902982
[TBL] [Abstract][Full Text] [Related]
12. Utilization of TREC and KREC quantification for the monitoring of early T- and B-cell neogenesis in adult patients after allogeneic hematopoietic stem cell transplantation.
Mensen A; Ochs C; Stroux A; Wittenbecher F; Szyska M; Imberti L; Fillatreau S; Uharek L; Arnold R; Dörken B; Thiel A; Scheibenbogen C; Na IK
J Transl Med; 2013 Aug; 11():188. PubMed ID: 23941115
[TBL] [Abstract][Full Text] [Related]
13. Newborn Screening for Severe T and B Cell Lymphopenia Using TREC/KREC Detection: A Large-Scale Pilot Study of 202,908 Newborns.
Marakhonov AV; Efimova IY; Mukhina AA; Zinchenko RA; Balinova NV; Rodina Y; Pershin D; Ryzhkova OP; Orlova AA; Zabnenkova VV; Cherevatova TB; Beskorovainaya TS; Shchagina OA; Polyakov AV; Markova ZG; Minzhenkova ME; Shilova NV; Larin SS; Khadzhieva MB; Dudina ES; Kalinina EV; Mudaeva DA; Saydaeva DH; Matulevich SA; Belyashova EY; Yakubovskiy GI; Tebieva IS; Gabisova YV; Irinina NA; Nurgalieva LR; Saifullina EV; Belyaeva TI; Romanova OS; Voronin SV; Shcherbina A; Kutsev SI
J Clin Immunol; 2024 Apr; 44(4):93. PubMed ID: 38578360
[TBL] [Abstract][Full Text] [Related]
14. TREC and KREC profiling as a representative of thymus and bone marrow output in patients with various inborn errors of immunity.
Dasouki M; Jabr A; AlDakheel G; Elbadaoui F; Alazami AM; Al-Saud B; Arnaout R; Aldhekri H; Alotaibi I; Al-Mousa H; Hawwari A
Clin Exp Immunol; 2020 Oct; 202(1):60-71. PubMed ID: 32691468
[TBL] [Abstract][Full Text] [Related]
15. Newborn blood spot screening test using multiplexed real-time PCR to simultaneously screen for spinal muscular atrophy and severe combined immunodeficiency.
Taylor JL; Lee FK; Yazdanpanah GK; Staropoli JF; Liu M; Carulli JP; Sun C; Dobrowolski SF; Hannon WH; Vogt RF
Clin Chem; 2015 Feb; 61(2):412-9. PubMed ID: 25502182
[TBL] [Abstract][Full Text] [Related]
16. Newborn Screening through TREC, TREC/KREC System for Primary Immunodeficiency with limitation of TREC/KREC. Comprehensive Review.
Shinwari K; Bolkov M; Tuzankina IA; Chereshnev VA
Antiinflamm Antiallergy Agents Med Chem; 2021; 20(2):132-149. PubMed ID: 32748762
[TBL] [Abstract][Full Text] [Related]
17. Newborn Screening for SCID and Other Severe Primary Immunodeficiency in the Polish-German Transborder Area: Experience From the First 14 Months of Collaboration.
Giżewska M; Durda K; Winter T; Ostrowska I; Ołtarzewski M; Klein J; Blankenstein O; Romanowska H; Krzywińska-Zdeb E; Patalan MF; Bartkowiak E; Szczerba N; Seiberling S; Birkenfeld B; Nauck M; von Bernuth H; Meisel C; Bernatowska EA; Walczak M; Pac M
Front Immunol; 2020; 11():1948. PubMed ID: 33178177
[TBL] [Abstract][Full Text] [Related]
18. Newborn screening for severe combined immunodeficiency: The results of the first pilot TREC and KREC study in Ukraine with involving of 10,350 neonates.
Boyarchuk O; Yarema N; Kravets V; Shulhai O; Shymanska I; Chornomydz I; Hariyan T; Volianska L; Kinash M; Makukh H
Front Immunol; 2022; 13():999664. PubMed ID: 36189201
[TBL] [Abstract][Full Text] [Related]
19. Use of V(D)J recombination excision circles to identify T- and B-cell defects and to monitor the treatment in primary and acquired immunodeficiencies.
Serana F; Chiarini M; Zanotti C; Sottini A; Bertoli D; Bosio A; Caimi L; Imberti L
J Transl Med; 2013 May; 11():119. PubMed ID: 23656963
[TBL] [Abstract][Full Text] [Related]
20. Retrospective analysis of TREC based newborn screening results and clinical phenotypes in infants with the 22q11 deletion syndrome.
Lingman Framme J; Borte S; von Döbeln U; Hammarström L; Oskarsdóttir S
J Clin Immunol; 2014 May; 34(4):514-9. PubMed ID: 24610337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
